Activist Jim Chud lived with HIV for decades. Before his death, he open up with Plus about the AIDS crisis, future of HIV, and what he's learned.
Drug-resistant strains of HIV are becoming more common. Here’s the 411 on what you need to know to suppress the viral uprising.
Can this drug help long-term survivors become undetectable while also improving their immune system?
A two-drug regimen for those just starting treatment has moved closer to FDA approval.
And rebuilt his life along the way.
Ibalizumab is designed to help when other drugs fail.
The Campbell Foundation bestows large grant to Stanford researchers to continue developing an HIV drug resistance test.
